NovoCure (NVCR) EPS (Basic) (2014 - 2026)
NovoCure (NVCR) posted quarterly EPS (Basic) of -$0.13 for Q2 2026, up 62.48% year-on-year from -$0.08 in Q2 2025, and up 78.34% on a QoQ basis from -$0.62 in Q1 2026.
NovoCure (NVCR) EPS (Basic) (2014 - 2026) Analysis & Trends
NovoCure (NVCR) has reported EPS (Basic) for 13 consecutive years, with -$0.13 the latest figure, recorded in Q2 2026.
- Quarterly EPS (Basic) rose 62.48% year-over-year to -$0.13 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.28 (up 16.42% YoY) and the FY2025 annual result came in at -$1.22, up 21.85% from the prior year.
- EPS (Basic) rose to -$0.13 in Q2 2026 per NVCR's latest filing, from -$0.62 in the prior quarter.
- Over the last five years, EPS (Basic) for NVCR reached as high as -$0.04 in Q1 2022 and fell as low as -$0.62 in Q1 2026.
- A 5-year average of -$0.35 and a median of -$0.34 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 1025.83% — and 2025, when it soared 64.05%.
- Year by year, EPS (Basic) stood at -$0.36 in 2022, then declined by 24.15% to -$0.44 in 2023, then sank by 38.15% to -$0.61 in 2024, then surged by 64.05% to -$0.22 in 2025, then jumped by 38.59% to -$0.13 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.13, -$0.62, and -$0.22 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Mar 31, 2026 | -0.62 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | -0.31 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -0.31 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | -0.50 |
| Dec 31, 2022 | -0.36 |
| Sep 30, 2022 | -0.25 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -0.04 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | -0.13 |